Domino's Pizza, Inc. vs Novartis AG — how do they compare? Domino's Pizza, Inc. trades at $356.34 (market cap $11.82B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 25× Domino's Pizza, Inc.'s market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| DPZ | NVS | |
|---|---|---|
Market Cap | $11.82B | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $467.30 | $168.62 |
52-Week Low | $282.89 | $119.31 |
Enterprise Value | $16.78B | $336.69B |
Dividend Yield | 2.23% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →